Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
University of Alabama at Birmingham
University of Alabama at Birmingham
National Cancer Institute (NCI)
Karyopharm Therapeutics Inc
AstraZeneca
Institut du Cancer de Montpellier - Val d'Aurelle
AstraZeneca
Genmab
Northwestern University
Northwestern University
M.D. Anderson Cancer Center
Atavistik Bio, Inc
Centre Oscar Lambret
Abramson Cancer Center at Penn Medicine
Pfizer
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
University of Miami
Queensland Centre for Gynaecological Cancer
DL Analytics